gonadarche ˌɡoʊnəˈdɑːrki refers earliest gonadal reproductive gland changes response pituitary gonadotropins ovaries females testes males begin grow increase production sex steroids especially estradiol ovary testis receptors follicle cells leydig cells respectively gonadotropins bind stimulate maturation gonads secretion estrogen certain disorders result changes timing nature processes gonadarche contrasted adrenarche gonadarche indicates true central puberty begun adrenarche independent maturational process loosely associated complete puberty influenced multitude factors including genetic prenatal nutritional environmental status parental pubescent age also influences age person starts puberty females usually begins around years old around years old body weight nutrition status evidenced effect puberty onset well due input adipose tissue hormonal puberty involves processes gonadarche adrenarche responsible maturation adrenal gland puberty stimulates development body odor axillary hair gonadarche starts macroneurons hypothalamus produce hormone called gonadotropinreleasing hormone gnrh responsible release hormones folliclestimulating hormone fsh luteinizing hormone lh produced anterior gonadarche marks beginning puberty process gonads primary reproductive organs mature following stimulation gonadotropin hormonereleasing hormone gnrh release release gnrh triggers release hormones activate maturation ovary release mediated primarily action hypothalamicpituitarygonadal axis hormonal signaling system active gestation fetal development reactivated around time gonadarche mediate gnrh pulsing release mentioned stimulates fsh lh release activation also influenced release protein kisspeptin time gonadarche production kisspeptin mediates gnrh pulse release puberty also gnrh activity fetal prior onset gonadarche stimulation hormones hypothalamus suppressed gabaergicreleasing inhibitory neurons central nervous input suppression also linked secretions estrogen immature ovaries onset gonadarche varies sexes average age onset averages around eleven years old males averages around nine years old females first clinical indication beginning adult breast development thelarche one five females may show signs pubarche clinical development across normal puberty better classified tanner stages sexual development breast pubic females pubertal growth spurt arise early puberty due direct stimulation sex steroids indirectly growth hormoneinsulinlike growth factor ghigf ovulation follicular functions stimulated gonadotropins released hypothalamicpituitarygonadal axis ovarian production progesterone estradiol come adult levels males gonadarche determined testicular volume greater ml genital stage greater equal pubarche defined pubic hair stage greater equal testicular volumes testes equal larger testis measurement used similarly females female larger breast stage one side stage gonadotropins release mediates maturation seminiferous tubules ready perform spermatogenesis primarily stimulation sertoli cells leydig cells similarly stimulted produce adult levels hormonal markers progression maturation differ sexes well tracking amh inhibin b levels useful males well gonadotropin androgen levels earlier puberty females also stable amh levels gonadotropin levels useful markers longer times long compared disorder central precocious puberty cpp also known progressive precocious gonadarche gnrhdependent precocious puberty occurs childs body initiates puberty earlier normally observed individuals cpp often experience early growth spurt bones maturing faster usual however since growth plates often close earlier without proper treatment children cpp may reach predicted adult height cpp caused premature activation incompletely suppressed hypothalamic gnrhgonadotropinreleasing hormone pulse gnrh pulse generator control center body regulates release two important hormones lh luteinizing hormone fsh follicle stimulating hormone hormones crucial fertility children condition undergo typical stages puberty including early development reproductive organs younger ages usual rare condition estimated incidence cases per million year based data collected cpp seen often young females males possibly due females less suppression pulse generator puberty around cases considered identifiable cause females males cases linked identifiable cause cases cpp associated specific gene mutations related gnrh gonadotropin preferred treatment cpp gnrh receptor medications modified variations natural gnrh degraded slower rate native gnrh stronger effect gnrh receptors results continuous gnrh stimulation pitutitary slows production gnrh decreasing gonadotropin secretion gnrh receptor agonists available us daily injections less frequent depot forms given every treating children cpp main goal preserve adult trying preserve adult height important keep precautions mind treatment significant amount variation height gained closely related age treatment started variation especially seen females additionally height outcomes usually calculated based difference projected adult height height recorded beginning treatment end treatment approach controversial frequent overestimations heights projected children cpp result health professionals rarely able accurately predict hight outcome people cpp psychological distress relation early puberty concern many considered stopping puberty children cpp means addressing issue reports illustrated poorer psychological outcomes children cpp early menarche however studies counter act claim find difference psychological outcomes gris cdgp conditions characterized extreme variation normal timing puberty gonadarche adrenarche delayed case resulting children developing later others delay development reproductive organs adrenal glands seen children cdgp individuals cdgp usually display decreased growth velocity early years life growth ultimately catch follow growth patterns seen fifth percentile childhood however growth velocity subsequently decreases early years adolescents due transient decrease gh growth hormone secretion often family history delayed puberty individuals cdgp often slower bone maturation predicted height often lower predicted genetic potential based heights biological currently reliable diagnostic tests conducted distinguish cdgp hypogonadism result diagnoses cdgp done ruling possible causes however laboratory studies done differentiate diagnosis cdgp hypogonadotropic hypogonadism using inhibin b antimüllerian hormone treating children cdgp goal improve growth well maintain average body proportions peak bone mass ensuring growth potential impaired emotional outcomes children also studied distress documented children due lack growth distress shown affect school performance social childhood obesity increased past several years particularly around research supporting link obesity delayed puberty females males still concrete studies supported obesity may effect earlier puberty females data consistent relation delayed puberty assessment start puberty harder identify males females thelarche breast bud development usually first sign puberty females children obesity may harder identify excess adipose tissue bread bud development leading potential false early puberty data suggests obesity lead later pubertal onset however markers early gonadal development harder identify males true marker onset puberty testicular enlargement ml larger requires invasive conclusion starting treatment early right diagnosis related significant success maintaining final adult height case cpp outcomes determined different factors advancement bone change case cdgp age childs body begins changing case cpp timing initiation duration hpg axis essentially charge regulating reproductive activity releasing estrogen progesterone humans returns back normal levels end treatment children generally normal development puberty finishing treatment normal levels typical much data longterm endocrine metabolic reproductive psychological outcomes httpsenwikipediaorgwikigonadarche